These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9579630)

  • 1. Thrombin and antithrombotics.
    Fenton JW; Ofosu FA; Brezniak DV; Hassouna HI
    Semin Thromb Hemost; 1998; 24(2):87-91. PubMed ID: 9579630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin structure and function: why thrombin is the primary target for antithrombotics.
    Fenton JW; Ofosu FA; Moon DG; Maraganore JM
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):69-75. PubMed ID: 1772999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin-activated thrombelastography for evaluation of thrombin interaction with thrombin inhibitors.
    Taketomi T; Szlam F; Vinten-Johansen J; Levy JH; Tanaka KA
    Blood Coagul Fibrinolysis; 2007 Dec; 18(8):761-7. PubMed ID: 17982317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane-bound enzyme complexes in blood coagulation.
    Mann KG
    Prog Hemost Thromb; 1984; 7():1-23. PubMed ID: 6099581
    [No Abstract]   [Full Text] [Related]  

  • 5. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interactions of blood coagulation factors (author's transl)].
    Cierniewski CS; Krajewski T
    Postepy Biochem; 1981; 27(1):81-105. PubMed ID: 6792614
    [No Abstract]   [Full Text] [Related]  

  • 7. HD1, a thrombin- and prothrombin-binding DNA aptamer, inhibits thrombin generation by attenuating prothrombin activation and thrombin feedback reactions.
    Kretz CA; Cuddy KK; Stafford AR; Fredenburgh JC; Roberts R; Weitz JI
    Thromb Haemost; 2010 Jan; 103(1):83-93. PubMed ID: 20062917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombin].
    Camici M; Sagripanti A; Di Mitri R
    Minerva Med; 2000; 91(5-6):105-12. PubMed ID: 11084844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the inhibition of both clot-associated thrombin and factor Xa more clinically relevant than either one alone?
    Meddahi S; Samama MM
    Blood Coagul Fibrinolysis; 2009 Apr; 20(3):207-14. PubMed ID: 19657318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of heparin and hirudin on thrombin generation and platelet aggregation after intrinsic activation of platelet rich plasma.
    Gallistl S; Muntean W; Leis HJ
    Thromb Haemost; 1995 Oct; 74(4):1163-8. PubMed ID: 8560429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Disseminated intravascular coagulation].
    Amir J
    Harefuah; 1972 Jul; 83(1):29-32. PubMed ID: 4264530
    [No Abstract]   [Full Text] [Related]  

  • 12. Bivalirudin, thrombin and platelets: clinical implications and future directions.
    Becker R; Butenas S; Carr M; Jaffer F; Kleiman NS; Marmur JD; Schneider DJ; Spiess BD; Steinhubl SR; Weitz JI
    J Invasive Cardiol; 2003 Aug; Suppl():2-15. PubMed ID: 23570139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro.
    Torbet J
    Thromb Haemost; 1995 May; 73(5):785-92. PubMed ID: 7482404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro studies on thrombin generation in citrated, r-hirudinized and heparinized whole blood.
    Kaiser B; Fareed J; Walenga JM; Hoppensteadt D; Markwardt F
    Thromb Res; 1991 Dec; 64(5):589-96. PubMed ID: 1808763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental pharmacology of hirunorm: a novel synthetic peptide thrombin inhibitor.
    Cirillo R; Lippi A; Subissi A; Agnelli G; Criscuoli M
    Thromb Haemost; 1996 Sep; 76(3):384-92. PubMed ID: 8883275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein C.
    Esmon CT
    Prog Hemost Thromb; 1984; 7():25-54. PubMed ID: 6099583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet coagulation-protein interactions.
    Walsh PN
    Semin Thromb Hemost; 2004 Aug; 30(4):461-71. PubMed ID: 15354267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic efficacy of thrombin inhibitor L-374,087: intravenous activity in a primate model of venous thrombus extension and oral activity in a canine model of primary venous and coronary artery thrombosis.
    Cook JJ; Gardell SJ; Holahan MA; Sitko GR; Stump GL; Wallace AA; Gilberto DB; Hare TR; Krueger JA; Dyer DL; Sanderson PE; Vacca JP; Shafer JA; Lynch JJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):503-10. PubMed ID: 10087043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration.
    Mosnier LO; Lisman T; van den Berg HM; Nieuwenhuis HK; Meijers JC; Bouma BN
    Thromb Haemost; 2001 Oct; 86(4):1035-9. PubMed ID: 11686321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP; Bernat A; Gaich C; Herbert M
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.